Effect of Dry Needling on Myofascial Trigger Point

Not Applicable

Completed

• Conditions: Pain

• Registration Number: NCT02107456
• Lead Sponsor: University of Social Welfare and Rehabilitation Science

Brief Summary

Myofascial trigger point is one of the most common causes of musculoskeletal disorders. Myofascial trigger point in upper trapezius has been reported as a symptom in patients with neck and upper thoracic pain. The purpose of this study was to investigate the prolonged effect of dry needling on myofascial trigger point in upper trapezius muscle.

Detailed Description

Pain intensity and Disability of arm, hand and shoulder (DASH) were collected at base line and at the end of treatment sessions, two weeks and three months follow up in both groups.

Study Timeline

• Study Start: 2012-07
• Primary Completion: 2013-02
• Study Completion: 2013-06
• Status Verified: 2014-04
• Study First Submitted: 2014-04-03
• Study First Submitted QC: 2014-04-07
• Last Update Submitted: 2014-04-07
• Study First Posted: 2014-04-08
• Last Update Posted: 2014-04-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 33

Inclusion Criteria

• 1. Presence of a palpable taut band in muscle.
• 2. Presence of a hypersensitive tender spot in the taut band.
• 3. Reproduction of the typical referred pain pattern of the MTP in response to compression. To detect active TrPs, TrP pressure tolerance was assessed using a mechanical pressure algometer. The investigator applied continuous pressure with the algometer with an approximate pressure of 2.5 kg/cm2.
• 4. Spontaneous presence of the typical referred pain pattern and/or patient recognition of the referred pain as familiar.
• 5- Pain of at least 30 mm on a visual analogue scale (VAS). The selected MTP of the UT muscle was located in the middle of the more nearly horizontal fibers of the UT 40.

Exclusion Criteria

• had a history of fibromyalgia syndrome, whiplash injury, cervical spine surgery and fracture, cervical radiculopathy, having therapy within the past month before the study
• any systematic disease such as rheumatism and tuberculosis or cervical myelopathy, multiple sclerosis
• local infection,
• pregnancy
• taking anticoagulants (e.g. warfarin)
• long-term steroid using

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Pain intensity	One year	Pain intensity using visual analogue scale (VAS) were collected at base line and at the end of treatment.

Secondary Outcome Measures

Name	Time	Method
Disability	One year	Disability of Arm and Shoulder was collected at base line and at the end of treatment.

Trial Locations

Locations (1)

University of Social Welfare and Rehabilitation Sciences; 🇮🇷 Tehran, Iran, Islamic Republic of